Philippe Guillot was granted a worldwide patent relating to the ability to graft molecules together back in 2004. Since then Philippe has developed a completely new process, embedded within AVE’s MGTP, by which to achieve this same outcome; this process is both scalable and low cost.
The MGTP can provide nano-material solutions for a vast array of applications from medicine delivery for the pharmaceutical industry, to advanced composites for the marine and aerospace industries, smart packaging for the logistics industry, photovoltaic paint and other solutions for the clean-tech industry, and engineered bio-materials for the green chemistry industry.
Molecular Grafting :
AVE’s MGTP has evolved out of years of laboratory research lead by Philippe Guillot.